Skip to main content
MedPathMedPath Home
Clinical Trials/ACTRN12613000562774
ACTRN12613000562774
Completed
未知

Renal endoluminal denervation to reduce sympathetic overdrive in dialysis-dependent patients.

niversity of Otago0 sites15 target enrollmentMay 17, 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsEnd Stage Kidney DiseaseRenal and Urogenital - Kidney diseaseCardiovascular - Other cardiovascular diseasesCardiovascular - Hypertension

Overview

Phase
未知
Intervention
Not specified
Conditions
End Stage Kidney Disease
Sponsor
niversity of Otago
Enrollment
15
Status
Completed
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 17, 2013
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Age \> 18 and able to give consent.
  • •On dialysis for at least 3 months.
  • •Clinically stable with no evidence of fluid overload, recent myocardial ischaemia or heart attack.
  • •Blood pressure \> 130/90 despite medications.
  • •They must have intact native renal kidneys

Exclusion Criteria

  • •Patients with significant renovascular abnormalities will not permitted to undergo the intervention. Anatomic abnormalities including multiple main renal arteries, short length main renal arteries, failed renal transplant, are exclusion criteria.
  • •Inability to give consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Withdrawn
Not Applicable
Sympathy Redo: redo of renal denervation with a second generation device.hypertensiehigh blood pressurehypertension10038430
NL-OMON42639niversitair Medisch Centrum Utrecht30
Completed
Phase 3
SYMPATHY: Renal sympathetic denervation as a new treatment for therapy resistant hypertension.hypertensiehigh blood pressurehypertension10038430
NL-OMON39831niversitair Medisch Centrum Utrecht570
Withdrawn
Not Applicable
SYMPATHY: Renal sympathetic denervation as a new treatment for therapy resistant hypertension: from rescue to resolve.hoge bloeddrukhypertension high blood pressure10038430
NL-OMON37568niversitair Medisch Centrum Utrecht260
Recruiting
Not Applicable
Renal denervation to improve heart failureSystolic heart failure
NL-OMON25325Erasmus Medical CenterRotterdam, the Netherlands70
Recruiting
Not Applicable
Endovascular Renal Sympathetic Denervation using the Boston Scientific Vessix V2 renal denervation system to Improve Heart FailureHeart failure10019280
NL-OMON40689Erasmus MC, Universitair Medisch Centrum Rotterdam70